Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

LitePoint Joins Continua Health Alliance

November 1, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Nov. 1, 2010 /- LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders. The alliance's mission is to improve the quality of personal healthcare and to establish a system...

TOPICS:

7,000 Bracelets For Hopeâ„¢ - A Rare Disease Awareness Campaign

November 1, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

DANA POINT, Calif., Nov. 1, 2010 /PRNewswire-USNewswire/ -- The Global Genes Project ( www.globalgenesproject.org ), a non-profit advocacy organization that aims to raise awareness about the prevalence of rare diseases worldwide, today launched the 7,000 Bracelets for Hope™...

TOPICS:

Humana's 3rd-quarter earnings rise 30 percent

November 1, 2010 2:45 am | by The Associated Press | News | Comments

Humana Inc.'s third-quarter net income climbed 30 percent partly on higher than expected medicals claims as Medicare Advantage enrollment rose.The health insurer also boosted its full-year earnings guidance on Monday.Humana is the second largest provider of Medicare Advantage plans, trailing...

Advertisement

Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD

November 1, 2010 1:34 am | by Bio-Medicine.Org | News | Comments

Medivir Notes That Partner Tibotec Announced Week 24 Interim Results Fro...

TOPICS:

Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®

November 1, 2010 1:34 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Nov. 1, 2010 /- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it has submitted a Marketing Authorization Application ("MAA") to the European Medicines Agency ("EMA") for Pixuvri® (pixantrone dimaleate) as monotherapy for the treatment of adult...

TOPICS:

Walsin Lihwa signs investment cooperation agreement with German solar energy company Solarion AG

November 1, 2010 12:37 am | by I-Micronews | News | Comments

Walsin Lihwa signed an investment cooperation agreement with Solarion AG, a Germany-based solar energy company in Leipzig.

Memjet launches high-speed, color on-demand printing technology for the labels and packaging markets

November 1, 2010 12:36 am | by I-Micronews | News | Comments

Memjet, the global leader in color printing technologies that provide remarkable speeds and affordability, will launch its color on-demand printing technology for the labels and packaging markets at PACK EXPO International 2010 (October 31-November 3, booth 3866).

November/December 2010 Digital Edition

November 1, 2010 12:00 am | Digital Editions | Comments

Inside: Read about different outsourcing generations in “4G Outsourcing Partnerships,” from Minnetronix. Shared are professionals’ opinions on the year in review, machining, and patient management devices. Additionally, read about innovative technologies for motors, compressor airs out pump shortcomings, pressure sensors, and medical imaging. Check out the selection of products, as well as the offerings for engineers in Design notes.

Advertisement

Racial and ethnic disparities impact care for children with frequent ear infections

October 31, 2010 8:38 pm | by EurekAlert | News | Comments

(American Academy of Otolaryngology -- Head and Neck Surgery) Racial and ethnic disparities among children with frequent ear infections significantly influence access to affordable health care, according to new research published in the November 2010 issue of Otolaryngology -- Head...

TOPICS:

Immune system assassin's tricks visualised for the first time

October 31, 2010 11:35 am | by EurekAlert | News | Comments

(Biotechnology and Biological Sciences Research Council) Scientists from the UK and Australia have seen the human immune system's assassin -- a protein called perforin -- in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council...

TOPICS:

How do we kill rogue cells?

October 31, 2010 11:35 am | by EurekAlert | News | Comments

(Science in Public) A team of Melbourne and London researchers have shown how a protein called perforin punches holes in, and kills, rogue cells in our bodies. Their discovery of the mechanism of this assassin is published today in the science journal Nature.

TOPICS:

Immune system's bare essentials used to speedily detect drug targets

October 31, 2010 11:32 am | by EurekAlert | News | Comments

(Johns Hopkins Medical Institutions) Scientists at Johns Hopkins have taken a less-is-more approach to designing effective drug treatments that are precisely tailored to disease-causing pathogens, such as viruses and bacteria, and cancer cells, any of which can trigger the body's immune...

TOPICS:

Track Down Awarepoint at AMSUS 116th Annual Meeting

October 31, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 31 /- WHO: Awarepoint , a provider of ZigBee-based real-time location solutions ( RTLS ) for hospitals, will exhibit in Booth #215 during AMSUS, the Society of the Federal Health Agencies. WHAT: Stop by and meet with Vice Admiral Harold Koenig, M.D. (retired) along with...

TOPICS:

Philips Introduces High Field Open MRI for Radiation Oncology

October 31, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

ANDOVER, Mass., Oct. 31 /- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the Philips Panorama High Field Open (HFO) Oncology Configuration for radiation therapy, a magnetic resonance (MR) imaging solution for dedicated oncology use, at this year's American Society for...

TOPICS:

CyberKnife Radiosurgery for Early-Stage Breast Cancer

October 31, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 31 /- Accuray Incorporated, (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading